Join now at #THT2022 as @HFpEF describes the results of the REDUCE HF-LAP II trial: the largest contemporary HFpEF device based trial.
Not the exclusion criteria for patients that may not tolerate a right sided volume load were defined by resting RA pressure, TR severity and PVR
Not the exclusion criteria for patients that may not tolerate a right sided volume load were defined by resting RA pressure, TR severity and PVR
This was a sick population with a median resting PCWP > 18. Meticulous definition of HFpEF with Exercise hemodynamics
The LA strain was quite low in both arms and could that affect who would respond @RBPatelMD?
The LA strain was quite low in both arms and could that affect who would respond @RBPatelMD?
To the results: as predicted there was no change in incidence of CVD ☠️ btw sham and IASD, but there was also not a difference in 🏥.
What accounts for this result?
This was a sick population overall and wonder if those w/ low LA/RA reservoir affected likelihood to respond
What accounts for this result?
This was a sick population overall and wonder if those w/ low LA/RA reservoir affected likelihood to respond
@ShelleyZieroth @SeguraCardio @rachkataria @docbhardwaj @HanCardiomd @GiuseppeGalati_ @KevinShahMD @a_h_ghoneem @AHajduczok
@BurkhoffMd @JerryEstepMD @SusanJosephMD @manreetkanwar @LindenfeldJoann @amorrismd @gtsayer @BrenerMickey @HRRosenblum @ersied727 @tremartyn @dranulala
@BurkhoffMd @JerryEstepMD @SusanJosephMD @manreetkanwar @LindenfeldJoann @amorrismd @gtsayer @BrenerMickey @HRRosenblum @ersied727 @tremartyn @dranulala
• • •
Missing some Tweet in this thread? You can try to
force a refresh
